Doctor Now, a telemedicine platform, has completed its Series B2 funding round. This investment, conducted three years after the Series B round in 2022, included participation from existing investors such as Hashed Ventures, Mirae Asset Capital, SmartStudy Ventures, Crit Ventures, and Primer Sazze Partners, as well as new investor Dayli Partners.

Lim Kyungho, Vice President of Doctor Now, stated, “During our growth phase, after the management restructuring under CEO Jung Jinwoong’s leadership, securing financial soundness while executing planned business initiatives and building growth momentum has served as a catalyst for earning the trust of our existing investors.”

Doctor Now recorded 1.11 million telemedicine consultations through the third quarter of 2025. This figure exceeds last year’s annual total of 760,000 consultations. In October alone, the platform recorded approximately 182,000 monthly consultations.

The company has partnerships with approximately 5,500 medical institutions, and through the third quarter of 2025, 18,970 pharmacies nationwide dispensed prescription medications through Doctor Now. There are 18,100 “preferred pharmacies” designated across the country, with approximately 104,000 app users having designated their preferred pharmacies.

Jung Jinwoong, CEO of Doctor Now, commented, “While telemedicine has not yet been fully legislated and various restrictions and regulatory guidelines remain in place, we will actively invest the newly secured funding in business growth and strengthening service infrastructure.”